Neurocrine Biosciences NBIX Inventory turnover
Inventory turnover at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's inventory turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's inventory turnover?
- Neurocrine Biosciences (NBIX) reported inventory turnover of 0.9× in Q1 2026.
- How has Neurocrine Biosciences's inventory turnover changed year-over-year?
- Neurocrine Biosciences's inventory turnover increased by 24.1% year-over-year, from 0.7× to 0.9×.
- What is the long-term trend for Neurocrine Biosciences's inventory turnover?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's inventory turnover has grown at a 12.1% compound annual growth rate (CAGR), from 1.9× to 3.1×.
- What does inventory turnover mean?
- How many times a year the company sells through and restocks its inventory.
- How do you interpret inventory turnover?
- Higher turnover ties up less cash in stock and reduces obsolescence risk, but too high can signal stock-outs and lost sales. Read against peers and the company's own history.
- How does inventory turnover compare across companies?
- Only meaningful for businesses that carry inventory; automatically null for asset-light and financial firms with no inventory line.